Welcome to the Second International Robin Sequence (RS) Consensus Meeting website “Building our Consensus in Robin Sequence: How do we know we are treating our patients in the best way”. This meeting is jointly hosted by the Division of Plastic and Reconstructive Surgery, The Hospital for Sick Children, Toronto and The Seattle Children’s Craniofacial Center to be held May 7th and 8th, 2017. The conference will be a 2 full day format held at the Peter Gilgan Center for Research and Learning, 686 Bay Street (corner of Elm and Bay Streets), adjacent to the Hospital for Sick Children, Toronto, Canada.
This symposium is designed to continue the discussion generated at the remarkably successful First International Robin Sequence Conference held in Utrecht, the Netherlands in November 2014. The objectives for this meeting are
- To facilitate clinical care and research progress for children with RS
- To develop multidisciplinary and multisite collaboration needed to advance care for children with RS
- Present scientific advances in the care of children with RS
It is anticipated that this conference will draw interest from many disciplines involved in the management of children with Robin Sequence including Plastic Surgery, Otolaryngology, Pediatrics, Respirology, Oral and Maxillofacial Surgery, Orthodontics, Dieticians, Occupational Therapy, and Genetics. The focus of this event is to focus on the optimization of care for these complex patients and to develop international collaborations for data collection and research using the format of didactic lectures, panel discussions and small group breakout sessions.
On behalf of the University of Toronto’s Division of Reconstructive and Plastic Surgery and The Seattle Children’s Craniofacial Center, we look forward to personally welcoming you to Toronto this spring.
- Facilitate clinical care and research progress for children with RS
- Develop a platform for the multidisciplinary and multi-site collaboration needed to advance care for children with RS
- Present scientic advances in the care of children with RS
Royal College of Physicians and Surgeons of Canada
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, approved by Continuing Professional Development, Faculty of Medicine, University of Toronto, up to a maximum of (14.5 hours).
The American Medical Association
Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 14.5 Category 1 CreditsTM. Information on the process to convert Royal College MOC credit to AMA credit can be found at: www.ama-assn.org/go/internationalcme
European Union for Medical Specialties
Live educational activities, occurring in Canada, recognized by the Royal College of Physicians and Surgeons of Canada as Accredited Group Learning Activities (Section 1) are deemed by the European Union of Medical Specialists (UEMS) eligible for ECMEC®.
Letters of Accreditation and Attendance
Letters of accreditation/attendance will be available online following the course. Participants will be e-mailed information within two weeks after completion of the course specifying how to obtain their letter of accreditation/attendance online. We do not routinely mail out accreditation letters.
It is the policy of University of Toronto, Faculty of Medicine, Continuing Education and Professional Development to ensure balance, independence, objectivity, and scientific rigor in all its individually accredited or jointly accredited educational programs. Speakers and/or planning committee members, participating in University of Toronto accredited programs, are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships within the last FIVE (5) years with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of facts. It remains for the audience to determine whether the speaker's outside interests may reflect a possible bias in either the exposition or the conclusions presented.